NYSEARCA:XBI

Spdr S&p Biotech Etf ETF News

etoro logo Buy XBI
*Your capital is at risk
$129.83
+2.07 (+1.62%)
At Close: Jun 03, 2026
Segment Wealth Management LLC raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.2% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 45,679 shares of the exchange traded funds stock after purchasing an additional 520 shares during the period. Segment Wealth Management LLCs holdings in SPDR S&P Biotech ETF were []

SPDR S&P Biotech ETF (NYSEARCA:XBI) Reaches New 1-Year Low at $114.84

02:12pm, Wednesday, 01'st Dec 2021 Dakota Financial News
SPDR S&P Biotech ETF (NYSEARCA:XBI)s stock price hit a new 52-week low during trading on Monday . The stock traded as low as $114.84 and last traded at $115.05, with a volume of 7732206 shares changing hands. The stock had previously closed at $116.78. The firms 50-day simple moving average is $125.18 and its 200-day []
Michael Yee, Jefferies biotech analyst and managing director, joins 'Power Lunch' to discuss how company stocks are reacting to rising omicron concerns and which are the best to play with Covid concer

Fifth Third Bancorp Grows Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

11:58am, Tuesday, 30'th Nov 2021 Dakota Financial News
Fifth Third Bancorp raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 196,139 shares of the exchange traded funds stock after purchasing an additional 4,368 shares during the period. []
XBI: 3 Reasons Why We Hold It In Our Retirement Portfolio
Hedge Funds Crushed By Surge In Moderna, The Third Most Shorted Name Over the weekend, we reported that even before last Fridat''s bloodbath, hedge funds suffered their worst week in six months because according to Goldman prime, the GS Equity Fundamental L/S Performance Estimate fell -1.57% between 11/19 and 11/25, driven by alpha of -1.12% which was "the worst alpha drawdown in nearly six months" and beta of -0.45% (from market exposure and market sensitivity combined). So it probably won''t come as a big shock that the worst Black Friday market crash in history did not reverse the ongoing woes of the 2 and 20 crowd, and once again failed to validate the "hedge" in "hedge fund" because according to Goldman prime, many hedge funds were again caught off-guard by news of the variant as they had bought US Go Outside (reopen) stocks and sold Stay-at Home names in the past week . Additionally, updated 13F data showed that mutual-funds are carrying sizable underweights coupled with large short positions in the vaccine names (particularly MRNA, which is the 3rd most shorted name, but also PFE).
Latitude Advisors LLC grew its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 131.4% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,207 shares of the exchange traded funds stock after purchasing an additional 2,389 shares during the quarter. Latitude Advisors []
Focused Wealth Management Inc raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 36,165 shares of the exchange traded funds stock after acquiring an additional 1,087 shares during the quarter. SPDR S&P []
Chatham Capital Group Inc. lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,861 shares of the exchange traded fund’s stock after selling 100 shares during the quarter. Chatham Capital Group Inc.’s […]
Prudential Financial Inc. lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.9% in the second quarter, Holdings Channel reports. The firm owned 12,305 shares of the exchange traded funds stock after buying an additional 1,598 shares during the period. Prudential Financial Inc.s holdings in SPDR S&P Biotech ETF were worth $1,666,000 at the []

Orleans Capital Management Corp Buys iShares U.S. ...

05:38pm, Thursday, 18'th Nov 2021 GuruFocus
Related Stocks: IHI , COP , ABBV , BLK , CMCSA , PLD , IBB , XLF , XBI , APD , VZ , WMT ,
Pacifica Partners Inc. increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 300.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 200 shares of the exchange traded fund’s stock after purchasing an additional 150 shares during the period. […]
Related Stocks: CIT , ASZ , KAHC , SABR , HZON , CNC , HIG , ATUS , POST , XBI , PPC , EGGF , EXC , J , MSFT , EGGF.U , RTX , LEGO ,
Related Stocks: PLTR , CNC , T , AJRD , BP , EPD , MIC , XBI , CWB , FIVN , EOG , AMH , SPY , PFPT , AON , QQQ , VALE , ARKG ,
Related Stocks: VTIP , SCHD , VYMI , GBDC , ADI , NAN , GE , VONV , VTWO , VONG , NRK , ELMS , XBI , MXIM , PTON , ACWI , ILF , ALXN ,
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE